An Open Label Study to Evaluate the Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea

Condition:   Rosacea Intervention:   Drug: AMG 334 Sponsors:   Messoud Ashina;   Danish Headache Center;   Novartis Pharmaceuticals;   Herlev and Gentofte Hospital Not yet recruiting

Source: ClinicalTrials.gov - June 5, 2020 Category: Research Source Type: clinical trials